Steven Cohen’s Oruka Therapeutics ORKA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$31.1M Buy
+373,455
New +$35.2M 0.03% 672
2026
Q1
– Sell
-600,000
Closed -$18.2M – 4653
2025
Q4
$18.2M Sell
600,000
-437,002
-42% -$12.2M 0.02% 954
2025
Q3
$19.9M Buy
1,037,002
+707,002
+214% +$10.5M 0.03% 549
2025
Q2
$3.7M Sell
330,000
-12,399
-4% -$129K 0.01% 1070
2025
Q1
$3.51M Sell
342,399
-18,333
-5% -$229K 0.01% 1057
2024
Q4
$6.99M Sell
360,732
-121,598
-25% -$2.97M 0.02% 838
2024
Q3
$11.8M Buy
+482,330
New +$16.8M 0.03% 588

Other funds holding ORKA

Steven Cohen's ORKA Position: Q3 2026 in Review

Steven Cohen opened a new position in Oruka Therapeutics (ORKA) in Q3 2026: 373,455 shares worth $31.1M. The stake represents 0.03% of the portfolio and ranks #672 among its holdings. This is a return to the name: Steven Cohen previously reported a position in ORKA as recently as Q4 2025.

Steven Cohen first reported a position in ORKA in Q3 2024 and has held it in 7 quarters since. 257 funds tracked by Wall St. Rank hold ORKA as of Q3 2026.

  • Steven Cohen held 373,455 shares of Oruka Therapeutics worth $31.1M as of Q3 2026.
  • Oruka Therapeutics was a new Steven Cohen position in Q3 2026.
  • Oruka Therapeutics made up 0.03% of Steven Cohen's portfolio in Q3 2026, its #672 holding.
  • Steven Cohen first reported a position in Oruka Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • 257 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.